The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mesa Nilda since 2020.
This trader's CIK number is 1756697.
At the time of last reporting, Mesa Nilda was the Officer of United Therapeutics Corp. (stock ticker symbol UTHR).
Also see all insider trading activities at United Therapeutics Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | UTHR | 0 | $0 | 645 | $187,045 | 0 | $0 |
| 2024 | UTHR | 0 | $0 | 1,070 | $345,096 | 900 | $0 |
| 2023 | UTHR | 0 | $0 | 1,362 | $313,665 | 880 | $0 |
| 2022 | UTHR | 0 | $0 | 290 | $77,885 | 1,080 | $0 |
| 2021 | UTHR | 0 | $0 | 0 | $0 | 1,680 | $0 |
| 2020 | UTHR | 0 | $0 | 0 | $0 | 4,960 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-24 | UTHR | Sale | 645 | 289.99 | 187,045 |
| 2024-12-30 | UTHR | Sale | 255 | 355.76 | 90,720 |
| 2024-11-08 | UTHR | Sale | 224 | 412.28 | 92,350 |
| 2024-07-13 | UTHR | Option Ex | 900 | .00 | 0 |
| 2024-06-25 | UTHR | Sale | 266 | 318.58 | 84,741 |
| 2024-03-27 | UTHR | Sale | 325 | 237.80 | 77,285 |
| 2023-12-19 | UTHR | Sale | 605 | 244.90 | 148,164 |
| 2023-09-13 | UTHR | Sale | 383 | 222.36 | 85,164 |
| 2023-07-07 | UTHR | Option Ex | 880 | .00 | 0 |
| 2023-05-05 | UTHR | Sale | 374 | 214.81 | 80,337 |
| 2022-11-07 | UTHR | Sale | 290 | 268.57 | 77,885 |
| 2022-07-08 | UTHR | Option Ex | 1,080 | .00 | 0 |
| 2021-06-26 | UTHR | Option Ex | 1,680 | .00 | 0 |
| 2020-06-26 | UTHR | Option Ex | 2,300 | .00 | 0 |
| 2019-10-31 | UTHR | Option Ex | 2,660 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mesa Nilda (Officer of United Therapeutics Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.